Hemgenix is given ‘conditional authorisation’. Which means the eu Medicines Agency resolved that the advantages of Hemgenix are bigger than its pitfalls, but the company must present more evidence following authorisation.According to the clinical gurus consulted by CADTH, there are various unmet wants for hemophilia B. First, those with hemophi